CD8A and neoplasm: In human TCs undergoing therapy-induced senescence, an upregulation of IFN-γ receptors is observed compared to proliferating cells, rendering senescent cells highly sensitive to the microenvironmental IFN-γ, triggering CD8+ T cell-mediated tumor rejection in an immunoreactive liver cancer model, contributing to the anti-tumor activity of immunotherapy.104